PACAP Modulation of CNS and Peripheral Inflammation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-319-35135-3_38
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Delayed Pituitary Adenylate Cyclase–Activating Polypeptide Delivery After Brain Stroke Improves Functional Recovery by Inducing M2 Microglia/Macrophage Polarization

  2015cited by this paper
• Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice

  2015cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats

  2014cited by this paper
• PACAP Enhances Barrier Properties of Cerebral Microvessels

  2014cited by this paper
• PACAP in the BNST Produces Anorexia and Weight Loss in Male and Female Rats

  2014cited by this paper
• PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress.

  2014cited by this paper
• Regulation of Bed Nucleus of the Stria Terminalis PACAP Expression by Stress and Corticosterone

  2014cited by this paper
• PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.

  2013cited by this paper
• The Role of Astrocytes in the Regulation of Synaptic Plasticity and Memory Formation

  2013cited by this paper
• The glial sodium-calcium exchanger: a new target for nitric oxide-mediated cellular toxicity.

  2013cited by this paper
• Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.

  2013cited by this paper
• VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair

  2013cited by this paper
• Excitotoxicity: bridge to various triggers in neurodegenerative disorders.

  2013cited by this paper
• Expression and distribution of pituitary adenylate cyclase-activating polypeptide receptor in reactive astrocytes induced by global brain ischemia in mice.

  2013cited by this paper
• Neuroprotective Effect of Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide on Spinal Cord Injury

  2012cited by this paper
• Possible neuroprotective property of nicotinic acetylcholine receptors in association with predominant upregulation of glial cell line‐derived neurotrophic factor in astrocytes

  2012cited by this paper
• Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation

  2012cited by this paper
• Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways.

  2011cited by this paper
• Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor

  2011cited by this paper
• Pituitary adenylate cyclase‐activating polypeptide protects astroglial cells against oxidative stress‐induced apoptosis

  2011cited by this paper
• PACAP centrally mediates emotional stress-induced corticosterone responses in mice

  2011cited by this paper
• Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling.

  2010cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Stimulates Proliferation of Reactive Astrocytes In Vitro

  2010cited by this paper
• Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide.

  2010cited by this paper
• Roles for Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Expression and Signaling in the Bed Nucleus of the Stria Terminalis (BNST) in Mediating the Behavioral Consequences of Chronic Stress

  2010cited by this paper
• Reflex control of immunity

  2009cited by this paper
• Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.

  2009cited by this paper
• The neurology of the immune system: neural reflexes regulate immunity.

  2009cited by this paper
• Catecholaminergic systems in stress: structural and molecular genetic approaches.

  2009cited by this paper
• Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

  2008cited by this paper
• Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.

  2008cited by this paper
• Sympathetic modulation of immunity: relevance to disease.

  2008cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor (PAC1R) co-localizes with activity-dependent neuroprotective protein (ADNP) in the mouse brains

  2008cited by this paper
• PACAP provides colonic protection against dextran sodium sulfate induced colitis

  2008cited by this paper
• Astrocytes in multiple sclerosis: A product of their environment

  2008cited by this paper
• Pituitary adenylate cyclase‐activating polypeptide is up‐regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage

  2007cited by this paper
• Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons.

  2007cited by this paper
• Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP

  2007cited by this paper
• Role of PACAP and VIP in astroglial functions.

  2007cited by this paper
• Hypothalamic and brainstem sources of pituitary adenylate cyclase‐activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat

  2007cited by this paper
• Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease

  2007cited by this paper
• Astrocyte glycogen and brain energy metabolism

  2007cited by this paper
• Microinfusion of Pituitary Adenylate Cyclase-Activating Polypeptide into the Central Nucleus of Amygdala of the Rat Produces a Shift from an Active to Passive Mode of Coping in the Shock-Probe Fear/Defensive Burying Test

  2007cited by this paper
• Autonomic innervation and regulation of the immune system (1987-2007).

  2007cited by this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6.

  2006cited by this paper
• Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression.

  2006cited by this paper
• Pituitary adenylate cyclase-activating peptide (PACAP) stimulates production of interleukin-6 in rat Müller cells

  2006cited by this paper
• Astrocyte dysfunction in neurological disorders: a molecular perspective

  2006cited by this paper
• PACAP Stimulates the Release of Interleukin‐6 in Cultured Rat Müller Cells

  2006cited by this paper
• Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.

  2005cited by this paper
• Ischemia‐induced programmed cell death in astrocytes

  2005cited by this paper
• Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons

  2005cited by this paper
• Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage.

  2004cited by this paper
• Pro‐regenerative properties of cytokine‐activated astrocytes

  2004cited by this paper
• Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain

  2004cited by this paper
• PACAP mRNA is expressed in rat spinal cord neurons

  2004cited by this paper
• Induction of neuropeptide gene expression and blockade of retrograde transport in facial motor neurons following local peripheral nerve inflammation in severe combined immunodeficiency and BALB/C mice.

  2004cited by this paper
• Astrocyte apoptosis: implications for neuroprotection.

  2004cited by this paper
• New roles for astrocytes: redefining the functional architecture of the brain.

  2003cited by this paper
• Astrocyte Protection of Neurons

  2003cited by this paper
• Possible Involvement of Astrocytes in Neuroprotection by the Cognitive Enhancer T-588

  2003cited by this paper
• Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes.

  2003cited by this paper
• Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression.

  2003cited by this paper
• Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes.

  2003cited by this paper
• Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor

  2002cited by this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit chemokine production in activated microglia

  2002cited by this paper
• CNS region‐specific regulation of glial glutamate transporter expression

  2002cited by this paper
• Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide.

  2002cited by this paper
• Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10.

  2002cited by this paper
• The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis.

  2002cited by this paper
• Pituitary adenylate cyclase‐activating peptide in the rat central nervous system: An immunohistochemical and in situ hybridization study

  2002cited by this paper
• Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

  2001cited by this paper
• Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B.

  2001cited by this paper
• Impairment of Mossy Fiber Long-Term Potentiation and Associative Learning in Pituitary Adenylate Cyclase Activating Polypeptide Type I Receptor-Deficient Mice

  2001cited by this paper
• Altered emotional behavior in PACAP-type-I-receptor-deficient mice.

  2001cited by this paper
• Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis

  2001cited by this paper
• Astrocytic factors protect neuronal integrity and reduce microglial activation in an in vitro model of N‐methyl‐d‐aspartate‐induced excitotoxic injury in organotypic hippocampal slice cultures

  2001cited by this paper
• Expression and Coupling of PACAP/VIP Receptors in Cortical Neurons and Type I Astrocytes

  2000cited by this paper
• Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury

  2000cited by this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), a Neuron-Derived Peptide Regulating Glial Glutamate Transport and Metabolism

  2000cited by this paper
• Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-α Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway

  2000cited by this paper
• Expression patterns and regulation of glutamate transporters in the developing and adult nervous system.

  1999cited by this paper
• Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death.

  1999cited by this paper
• Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes

  1999cited by this paper
• Axotomy‐induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus

  1999cited by this paper
• PACAP Gene Expression in Neurons of the Rat Hypothalamo-Pituitary-Adrenocortical Axis Is Induced by Endotoxin and Interleukin-1β

  1999cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP) expression in sympathetic preganglionic projection neurons to the superior cervical ganglion.

  1998cited by this paper
• Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat

  1998cited by this paper
• Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat

  1998cited by this paper
• Light and electron microscopic studies of pituitary adenylate cyclase-activating peptide (PACAP) – immunoreactive neurons in the enteric nervous system of rat small and large intestine

  1998cited by this paper
• Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation

  1997cited by this paper
• Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides

  1997cited by this paper
• Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus.

  1997cited by this paper
• PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Pituitary Adenylate Cyclase‐Activating Polypeptides, PACAP‐38 and PACAP‐27, Regulation of Sympathetic Neuron Catecholamine, and Neuropeptide Y Expression Through Activation of Type I PACAP/VIP Receptor Isoforms a

  1996cited by this paper
• Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Is a Regulator of Astrocytes: PACAP Stimulates Proliferation and Production of Interleukin 6 (IL‐6), but not Nerve Growth Factor (NGF), in Cultured Rat Astrocyte

  1996cited by this paper
• Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat

  1996cited by this paper
• Distribution of the mRNA for a pituitary adenylate cyclase‐activating polypeptide receptor in the rat brain: An in situ hybridization study

  1996cited by this paper
• Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Regulation of Sympathetic Neuron Neuropeptide Y and Catecholamine Expression

  1995cited by this paper

• Pituitary adenylate cyclase‐activating peptide: Potential roles in the pathophysiology and complications of cirrhosis

  2020cites this paper
• Pituitary adenylate cyclase–activating polypeptide (PACAP-38) plays an inhibitory role against inflammation induced by chemical damage to zebrafish hair cells

  2018cites this paper